Anna F. Lee

ORCID: 0000-0002-6703-0656 · 7 papers in corpus · active 2011-2024

Study types

  • article 5
  • other 2

Condition tags

  • endometriosis 7
  • mesh:D004715 6
  • endometrioma 4
  • die_deep_infiltrating 3
  • dyspareunia 2
  • mesh:D004412 1
  • mesh:D004414 1
  • bowel_endometriosis 1
  • mesh:D017699 1
  • dysmenorrhea 1
article 2024
Biomolecules ·doi:10.3390/biom14050583

Endometriosis is a gynecological disorder associated with local inflammation and neuroproliferation. Increased nerve bundle density has been attributed to increased expression of nerve growth factor (NGF) and interleukin-1β (IL-1β). Immunoh…

article 2024
Human Reproduction ·doi:10.1093/humrep/deae269

STUDY QUESTION: Is there an association between the somatic loss of PTEN (phosphatase and tensin homolog) and ARID1A (AT-rich interaction domain 1A) and endometriosis disease severity and worse clinical outcomes? SUMMARY ANSWER: Somatic PTE…

article 2023
The journal of pathology. Clinical research ·doi:10.1002/cjp2.317

The clinical phenotype of somatic mutations in endometriosis is unknown. The objective was to determine whether somatic KRAS mutations were associated with greater disease burden in endometriosis (i.e. more severe subtypes and higher stage)…

other 2019
PloS one ·doi:10.1371/journal.pone.0219064

PURPOSE: Deep infiltrating endometriosis (DIE) is defined as an endometriotic lesion penetrating to a depth of >5 mm and is associated with pelvic pain, but the underlying mechanisms are unclear. Our objective is to investigate whether plas…

article 2018
Human Reproduction ·doi:10.1093/humrep/dey332

STUDY QUESTION: Does incisional endometriosis (IE) harbor somatic cancer-driver mutations? SUMMARY ANSWER: We found that approximately one-quarter of IE cases harbor somatic-cancer mutations, which commonly affect components of the MAPK/RAS…

article 2015
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719115623644
other 2011
The Journal of Pathology ·doi:10.1002/path.2911

Mutation of the ARID1A gene and loss of the corresponding protein BAF250a has recently been described as a frequent event in clear cell and endometrioid carcinomas of the ovary. To determine whether BAF250a loss is common in other malignanc…